Cancer Relevance Statement: I am an expert in modulating systemic inflammation to improve cancer outcomes via dietary modifications. My bench to bedside and back approach allows for novel discoveries that are easily translated to the clinic. My research interest is to change the landscape of cancer care by empowering patients to use dietary interventions to improve outcomes. The overarching goal of my laboratory is to increase sensitivity of tumors with a poor response to standard therapies. To accomplish this, the lab uses diet to alter cell metabolism via signaling pathways to increase cancer cells’ vulnerability to cytotoxic therapy. Through our studies, we have found new methods for treating tumors, which has led to the development of innovative clinical trials.
PubMed Search
Cancer Relevant Publications By Nicole L. Simone While A Cancer Center Member Since 1/1/2000.
Scopus CiteScores Released in 2025 for Journal in [] after Journal Name.
Sidney Kimmel Comprehensive Cancer Center Bibliography - Author: SIMONE N [Just Cancer Related]
| ¶ 1. | Jacoby JL, Calderon Aparicio A, François NB, Thapar M, Burke SE, Xu S, DeAngelis T, Shastri A, Tran PT, Simone NL[CRiC]. Standardizing caloric restriction for preclinical cancer research. Biotechniques[3.3]. 2025 Oct 24:1-10. [Epub ahead of print] PMID: 41133872 DOI: 10.1080/07366205.2025.2577029 ( Abstract ) iCite Citation Count: 0 (01/01/2026)
|
| ¶ # 2. | Fracasso PM, Simone NL[CRiC], Si Lim SJ, Reckamp KL, Sosa JA, Lieu C, Lee C, Werner TL, Ly QP, Vose JM, White J, Honeycutt H, Shaw K, Cameron K, O'Brien DM, Wilke LG. Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines. JCO Oncol Pract[7.5]. 2025 Sep 24:OP2500073. [Epub ahead of print] PMID: 40991878 DOI: 10.1200/OP-25-00073 ( Abstract ) iCite Citation Count: 0 (01/01/2026)
|
| * 3. | Simone NL[CRiC], Burke S, Hamade K, Leader A[CRiC], McNair C[CRiC]. Mapping disparities: identifying cancer care gaps in sexual and gender minority patients. J Natl Cancer Inst Monogr[3.8]. 2025 Jul 01; 2025(69):153-160. PMID: 40671549 PMCID: PMC12268168 PII: 8203044 DOI: 10.1093/jncimonographs/lgaf030 ( Abstract ) iCite Citation Count: 0 (01/01/2026)
|
| ‡ * 4. | Logan JA, Sadhu S, Hazlewood C, Denton M, Burke SE, Simone-Soule CA, Black C, Ciaverelli C, Stulb J, Nourzadeh H, Vinogradskiy Y[CRiC], Leader A[CRiC], Dicker AP[CRiC], Choi W, Simone NL[CRiC]. Bridging Gaps in Cancer Care: Utilizing Large Language Models for Accessible Dietary Recommendations. Nutrients[9.1]. 2025 Mar 28; 17(7). PMID: 40218934 PMCID: PMC11990115 PII: nu17071176 DOI: 10.3390/nu17071176 ( Abstract ) iCite Citation Count: 1 (01/01/2026)
|
| ¶ † +* 5. | Mastrolonardo EV, Llerena P, De Ravin E, Nunes K, Kaki PC, Bridgham KM, Amin DR, Campbell DJ, Philips R, Koeneman SH, Cognetti DM[TaCO], Luginbuhl AJ[TaCO], Simone NL[CRiC], Johnson JM[MORA], Curry JM[MORA]. Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types. Cancer[11.5]. 2025 Mar 15; 131(6):e35799. PMID: 40069917 PMCID: PMC11897419 DOI: 10.1002/cncr.35799 ( Abstract ) iCite Citation Count: 6 iCite RCR: 3.00 (01/01/2026)
|
| ¶ * 6. | Poiset SJ, Lombardo J, Castillo E, Castillo R, Jones B, Miften M, Kavanagh B, Dicker AP[CRiC], Boyle C, Simone NL[CRiC], Movsas B, Grills I, Rusthoven CG, Vinogradskiy Y[CRiC], Wilson L[CRiC]. Patient-Reported Outcomes: Comparing Functional Avoidance and Standard Thoracic Radiation Therapy in Lung Cancer. JCO Clin Cancer Inform[4.8]. 2025 Feb; 9:e2400202. PMID: 39903899 PMCID: PMC11801246 DOI: 10.1200/CCI-24-00202 ( Abstract ) iCite Citation Count: 0 (01/01/2026)
|
| ¶ † 7. | Sutera P, Song Y, Shetty AC, English K, Van der Eecken K, Guler OC, Wang J, Cao Y, Bazyar S, Verbeke S, Van Dorpe J, Fonteyne V, De Laere B, Mishra M, Rana Z, Molitoris J, Ferris M, Kiess A, Song DY, DeWeese T, Pienta KJ, Barbieri C, Marchionni L, Ren L, Sawant A, Simone N[CRiC], Berlin A, Onal C, Tran PT, Ost P, Deek MP. Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer. Eur Urol Oncol[13]. 2025 Feb; 8(1):111-118. PMID: 38862340 PII: S2588-9311(24)00142-1 DOI: 10.1016/j.euo.2024.05.011 ( Abstract ) iCite Citation Count: 4 (01/01/2026)
|
| ¶ ‡ 8. | Wang JH, Deek MP, Mendes AA, Song Y, Shetty A, Bazyar S, Van der Eecken K, Chen E, Showalter TN, Royce TJ, Todorovic T, Huang HC, Houck SA, Yamashita R, Kiess AP, Song DY, Lotan T, DeWeese T, Marchionni L, Ren L, Sawant A, Simone N[CRiC], Berlin A, Onal C, Esteva A, Feng FY, Tran PT, Sutera P, Ost P. Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer. Radiother Oncol[9.1]. 2025 Jan; 202:110618. PMID: 39510141 PMCID: PMC11663099 PII: S0167-8140(24)04280-4 DOI: 10.1016/j.radonc.2024.110618 ( Abstract ) iCite Citation Count: 9 iCite RCR: 4.50 (01/01/2026)
|
| ¶ ‡ 9. | Cao Y, Sutera P, Silva Mendes W, Yousefi B, Hrinivich T, Deek M, Phillips R, Song D, Kiess A, Cem Guler O, Torun N, Reyhan M, Sawant A, Marchionni L, Simone NL[CRiC], Tran P, Onal C, Ren L. Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics. Radiother Oncol[9.1]. 2024 Oct; 199:110443. PMID: 39094629 PMCID: PMC11405100 PII: S0167-8140(24)00713-8 DOI: 10.1016/j.radonc.2024.110443 ( Abstract ) iCite Citation Count: 6 iCite RCR: 1.25 (01/01/2026)
|
| ¶ † * 10. | Lombardo J, Castillo E, Castillo R, Miller R, Jones B, Miften M, Kavanagh B, Dicker A[CRiC], Boyle C, Leiby B[CRiC], Banks J, Simone NL[CRiC], Movsas B, Grills I, Guerrero T, Rusthoven CG, Vinogradskiy Y[CRiC]. Prospective Trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report. Int J Radiat Oncol Biol Phys[10.9]. 2024 Oct 01; 120(2):593-602. PMID: 38614278 PMCID: PMC11381170 PII: S0360-3016(24)00476-0 DOI: 10.1016/j.ijrobp.2024.03.046 ( Abstract ) iCite Citation Count: 3 iCite RCR: 0.99 (01/01/2026)
|
| ‡ * 11. | Calderon-Aparicio A, He J[CRiC], Simone NL[CRiC]. S6K1 Controls DNA Damage Signaling Modulated by the MRN Complex to Induce Radioresistance in Lung Cancer. Int J Mol Sci[9]. 2024 Sep 28; 25(19). PMID: 39408794 PMCID: PMC11477310 PII: ijms251910461 DOI: 10.3390/ijms251910461 ( Abstract ) iCite Citation Count: 2 iCite RCR: 0.53 (01/01/2026)
|
| +* 12. | Cappelli L, Uppendahl A, Gardner C, Khan M, Kayne A, Vemula S, Poiset SJ, Zhan T, Judy KD, Andrews DW[IRT], Simone NL[CRiC], Alnahhas I[IRT], Shi W[MORA]. Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM). J Clin Neurosci[3.9]. 2024 Sep; 127:110754. PMID: 39068727 PII: S0967-5868(24)00280-7 DOI: 10.1016/j.jocn.2024.07.015 ( Abstract ) iCite Citation Count: 0 iCite RCR: 0.00 (01/01/2026)
|
| † * 13. | Wen KY[CRiC], Burke SE, Jacoby JL, Liang J, Simone NL[CRiC]. RE: Dietary interventions in cancer: a systematic review of all randomized controlled trials. J Natl Cancer Inst[17.4]. 2024 Aug 01; 116(8):1402-1403. PMID: 38889290 PMCID: PMC11308162 PII: 7695880 DOI: 10.1093/jnci/djae122 ( Abstract ) iCite Citation Count: 1 iCite RCR: 0.17 (01/01/2026)
|
| ¶ § # + 14. | Esquea EM, Ciraku L, Young RG, Merzy J, Talarico AN, Ahmed NN, Karuppiah M, Ramesh A, Chatoff A, Crispim CV, Rashad AA, Cocklin S, Snyder NW, Beld J, Simone NL[CRiC], Reginato MJ[TaCO], Dick A. Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells. Front Pharmacol[8.9]. 2024 May 16; 15:1394685. PMID: 38818373 PMCID: PMC11137182 PII: 1394685 DOI: 10.3389/fphar.2024.1394685 ( Abstract ) iCite Citation Count: 14 iCite RCR: 2.73 (01/01/2026)
|
| * 15. | Nelson NG, Burke SE, Cappelli L, Matlack LE, Smith AP, Francois N, Lombardo JF, Shah YB, Wen KY[CRiC], Shafi AA, Simone NL[CRiC]. Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient Profiles. Clocks Sleep[4.2]. 2024 Mar 21; 6(1):200-210. PMID: 38534802 PMCID: PMC10968878 PII: clockssleep6010014 DOI: 10.3390/clockssleep6010014 ( Abstract ) iCite Citation Count: 1 iCite RCR: 0.20 (01/01/2026)
|
| ¶ +* 16. | Choi W, Jia Y, Kwak J, Werner-Wasik M[MORA], Dicker AP[CRiC], Simone NL[CRiC], Storozynsky E[CRiC], Jain V, Vinogradskiy Y[CRiC]. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy. JCO Clin Cancer Inform[4.8]. 2024 Mar; 8:e2300241. PMID: 38452302 PMCID: PMC10939651 DOI: 10.1200/CCI.23.00241 ( Abstract ) iCite Citation Count: 3 iCite RCR: 0.49 (01/01/2026)
|
| ‡ * 17. | Zhao L, Wang Y, Sun X, Zhang X, Simone N[CRiC], He J[CRiC]. ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. Int J Mol Sci[9]. 2024 Feb 17; 25(4). PMID: 38397056 PMCID: PMC10888698 PII: ijms25042382 DOI: 10.3390/ijms25042382 ( Abstract ) iCite Citation Count: 6 iCite RCR: 1.93 (01/01/2026)
|
| ¶ # 18. | Hoang T, Sutera P, Nguyen T, Chang J, Jagtap S, Song Y, Shetty AC, Chowdhury DD, Chan A, Carrieri FA, Hathout L, Ennis R, Jabbour SK, Parikh R, Molitoris J, Song DY, DeWeese T, Marchionni L, Ren L, Sawant A, Simone N[CRiC], Lafargue A, Van Der Eecken K, Bunz F, Ost P, Tran PT, Deek MP. TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment. Prostate[5]. 2024 Jan; 84(1):87-99. PMID: 37812042 DOI: 10.1002/pros.24629 ( Abstract ) iCite Citation Count: 1 iCite RCR: 0.28 (01/01/2026)
|
| § * 19. | Butryn ML[CRiC], Hagerman CJ, Crane NT, Ehmann MM, Forman EM[CRiC], Milliron BJ, Simone NL[CRiC]. A Proof-of-Concept Pilot Test of a Behavioral Intervention to Improve Adherence to Dietary Recommendations for Cancer Prevention. Cancer Control[4]. 2023 Jan-Dec; 30:10732748231214122. PMID: 37950612 PMCID: PMC10640808 DOI: 10.1177/10732748231214122 ( Abstract ) iCite Citation Count: 3 iCite RCR: 0.49 (01/01/2026)
|
| ¶ * 20. | McIntire RK, Juon HS[CRiC], Keith SW[CRiC], Simone NL[CRiC], Waters D, Lewis E, Zeigler-Johnson C. A novel method for measuring the burden of breast cancer in neighborhoods. Prev Med Rep[4.3]. 2023 Jun; 33:102218. PMID: 37223584 PMCID: PMC10201825 PII: S2211-3355(23)00109-2 DOI: 10.1016/j.pmedr.2023.102218 ( Abstract ) iCite Citation Count: 2 iCite RCR: 0.10 (01/01/2026)
|
| # * 21. | Nelson NG, Lombardo JF, Shimada A, Ruggiero ML, Smith AP, Ko K, Leader AE[CRiC], Mitchell EP[CRiC], Simone NL[CRiC]. Physician Perceptions on Cancer Screening for LGBTQ+ Patients. Cancers (Basel)[8.8]. 2023 Jun 01; 15(11). PMID: 37296978 PMCID: PMC10252104 PII: cancers15113017 DOI: 10.3390/cancers15113017 ( Abstract ) iCite Citation Count: 3 iCite RCR: 0.59 (01/01/2026)
|
| ¶ * 22. | Lombardo J, Schmucker AM, Keith SW[CRiC], Ronghe A, Smith A, Ali AS, Niazi M, Denton M, Swartz K[CRiC], Chapman A[CRiC], Simone NL[CRiC]. Markers and associations of nutrition identified in a senior adult oncology clinic. J Geriatr Oncol[4.7]. 2023 Jan; 14(1):101388. PMID: 36253248 PII: S1879-4068(22)00237-5 DOI: 10.1016/j.jgo.2022.10.003 ( Abstract ) iCite Citation Count: 1 iCite RCR: 0.21 (01/01/2026)
|
| § * 23. | Horgan OZ, Crane NT, Forman EM[CRiC], Milliron BJ, Simone NL[CRiC], Zhang F, Butryn ML[CRiC]. Optimizing an mHealth Intervention to Change Food Purchasing Behaviors for Cancer Prevention: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc[2.4]. 2022 Jun 24; 11(6):e39669. PMID: 35749216 PMCID: PMC9270710 PII: v11i6e39669 DOI: 10.2196/39669 ( Abstract ) iCite Citation Count: 1 iCite RCR: 0.19 (06/02/2025)
|
| ¶ +* 24. | Lombardo J, Ko K, Shimada A, Nelson N, Wright C, Chen J, Maity A, Ruggiero ML, Richard S[MORA], Papanagnou D, Mitchell E[CRiC], Leader A[CRiC], Simone NL[CRiC]. Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity. Cancer Causes Control[4.3]. 2022 Apr; 33(4):559-582. PMID: 34984592 PMCID: PMC9076188 PII: 10.1007/s10552-021-01549-4 DOI: 10.1007/s10552-021-01549-4 ( Abstract ) iCite Citation Count: 22 iCite RCR: 3.19 (06/02/2025)
|
| ‡ + 25. | Nelson N, Lombardo J, Matlack L, Smith A, Hines K, Shi W[MORA], Simone NL[CRiC]. Chronoradiobiology of Breast Cancer: The Time Is Now to Link Circadian Rhythm and Radiation Biology. Int J Mol Sci[9]. 2022 Jan 25; 23(3). PMID: 35163264 PMCID: PMC8836288 PII: ijms23031331 DOI: 10.3390/ijms23031331 ( Abstract ) iCite Citation Count: 17 iCite RCR: 1.85 (06/02/2025)
|
| ¶ # * 26. | Maisel BA, Yi M, Peck AR, Sun Y, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Nevalainen MT, Tanaka T, Simone N[CRiC], Wang LL, Rui H, Chervoneva I[CRiC]. Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer. Cancers (Basel)[8.8]. 2022 Jan 08; 14(2). PMID: 35053472 PMCID: PMC8773496 PII: cancers14020308 DOI: 10.3390/cancers14020308 ( Abstract ) iCite Citation Count: 15 iCite RCR: 1.47 (06/02/2025)
|
| ¶ 27. | Squeo GC, Lattimore CM, Simone NL[CRiC], Suralik G, Dutta SW, Schad MD, Su L, Libby B, Janowski EM, Showalter SL, Lobo JM, Showalter TN. A comparative study using time-driven activity-based costing in single-fraction breast high-dose rate brachytherapy: An integrated brachytherapy suite vs. decentralized workflow. Brachytherapy[3.1]. 2022; 21(3):334-340. PMID: 35125328 PMCID: PMC9149052 PII: S1538-4721(21)00543-2 DOI: 10.1016/j.brachy.2021.12.006 ( Abstract ) iCite Citation Count: 7 iCite RCR: 1.21 (06/02/2025)
|
| ‡ * 28. | Shastri AA, Lombardo J, Okere SC, Higgins S, Smith BC, DeAngelis T, Palagani A, Hines K, Monti DA[CRiC], Volpe S, Mitchell EP[CRiC], Simone NL[CRiC]. Personalized Nutrition as a Key Contributor to Improving Radiation Response in Breast Cancer. Int J Mol Sci[9]. 2021 Dec 24; 23(1). PMID: 35008602 PMCID: PMC8745527 PII: ijms23010175 DOI: 10.3390/ijms23010175 ( Abstract ) iCite Citation Count: 7 iCite RCR: 0.42 (06/02/2025)
|
| § +* 29. | Ciraku L, Moeller RA, Esquea EM, Gocal WA, Hartsough EJ[TaCO], Simone NL[CRiC], Jackson JG, Reginato MJ[TaCO]. An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth. J Vis Exp[2]. 2021 Sep 22(175). PMID: 34633392 PMCID: PMC8751251 DOI: 10.3791/62617 ( Abstract ) iCite Citation Count: 8 iCite RCR: 0.54 (06/02/2025)
|
| ¶ † 30. | Manukian G, Kivolowitz C, DeAngelis T, Shastri AA, Savage JE, Camphausen K, Rodeck U, Zarif JC, Simone NL[CRiC]. Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells. Int J Radiat Oncol Biol Phys[10.9]. 2021 Aug 01; 110(5):1341-1349. PMID: 33647370 PMCID: PMC8286289 PII: S0360-3016(21)00207-8 DOI: 10.1016/j.ijrobp.2021.02.029 ( Abstract ) iCite Citation Count: 27 iCite RCR: 1.70 (06/02/2025)
|
| † 31. | Zaorsky NG, Allenby T, Lin J, Rosenberg J, Simone NL[CRiC], Schmitz KH. Exercise Therapy and Radiation Therapy for Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys[10.9]. 2021 Jul 15; 110(4):973-983. PMID: 33220396 PII: S0360-3016(20)34546-6 DOI: 10.1016/j.ijrobp.2020.11.024 ( Abstract ) iCite Citation Count: 16 iCite RCR: 1.22 (06/02/2025)
|
| # + 32. | Dan T, Shastri AA, Palagani A, Buraschi S, Neill T, Savage JE, Kapoor A, DeAngelis T, Addya S, Camphausen K, Iozzo RV[TaCO], Simone NL[CRiC]. miR-21 Plays a Dual Role in Tumor Formation and Cytotoxic Response in Breast Tumors. Cancers (Basel)[8.8]. 2021 Feb 20; 13(4). PMID: 33672628 PMCID: PMC7924198 PII: cancers13040888 DOI: 10.3390/cancers13040888 ( Abstract ) iCite Citation Count: 30 iCite RCR: 2.75 (06/02/2025)
|
| + 33. | Taylor JM, Song A, Nowak K, Dan T, Simone B, Harrison A, Doyle L, Lockamy V, Anne P[MORA], Simone N[CRiC]. Dosimetric Comparisons of Simulation Techniques for Left-Sided Breast Cancer in the COVID-19 Era: Techniques to Reduce Viral Transmission and Respect the Therapeutic Ratio. Cureus[UK]. 2021 Feb 15; 13(2):e13354. PMID: 33747655 PMCID: PMC7968704 DOI: 10.7759/cureus.13354 ( Abstract ) iCite Citation Count: 0 iCite RCR: 0.00 (06/02/2025)
|
| +* 34. | Miller RC, Simone BA, Lombardo JF, Taylor J, Nowak-Choi K, Ko K, Ferguson L, Donnelly A, Ali AS, Shi W[MORA], Dicker AP[CRiC], Simone NL[CRiC]. A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual. Telemed Rep[2.6]. 2021; 2(1):171-178. PMID: 34250522 PMCID: PMC8259074 PII: 10.1089/tmr.2021.0007 DOI: 10.1089/tmr.2021.0007 ( Abstract ) iCite Citation Count: 9 iCite RCR: 0.65 (06/02/2025)
|
| ¶ 35. | Allenby TH, Crenshaw ML, Mathis K, Champ CE, Simone NL[CRiC], Schmitz KH, Tchelebi LT, Zaorsky NG. A systematic review of home-based dietary interventions during radiation therapy for cancer. Tech Innov Patient Support Radiat Oncol[3.7]. 2020 Dec; 16:10-16. PMID: 32995577 PMCID: PMC7501444 PII: S2405-6324(20)30018-4 DOI: 10.1016/j.tipsro.2020.08.001 ( Abstract ) iCite Citation Count: 10 iCite RCR: 0.83 (06/02/2025)
|
| # + 36. | Wright CM, Shastri AA, Bongiorno E, Palagani A, Rodeck U[IRT], Simone NL[CRiC]. Is Host Metabolism the Missing Link to Improving Cancer Outcomes? Cancers (Basel)[8.8]. 2020 Aug 19; 12(9). PMID: 32825010 PMCID: PMC7564800 PII: cancers12092338 DOI: 10.3390/cancers12092338 ( Abstract ) iCite Citation Count: 3 iCite RCR: 0.20 (06/02/2025)
|
| ¶ 37. | Andersen JP, Nielsen MW, Simone NL[CRiC], Lewiss RE, Jagsi R. COVID-19 medical papers have fewer women first authors than expected. Elife[UK]. 2020 06 15; 9. PMID: 32538780 PMCID: PMC7304994 PII: 58807 DOI: 10.7554/eLife.58807 ( Abstract ) iCite Citation Count: 210 iCite RCR: 13.57 (06/02/2025)
|
| † 38. | Lombardo J, Simone N[CRiC]. Care of Transgender Persons. N Engl J Med[96.4]. 2020 04 09; 382(15):1481. PMID: 32268037 PII: 10.1056/NEJMc2000825#sa1 DOI: 10.1056/NEJMc2000825 ( Abstract ) iCite Citation Count: 0 iCite RCR: 0.00 (06/02/2025)
|
| ¶ † 39. | Xavier JB, Young VB, Skufca J, Ginty F, Testerman T, Pearson AT, Macklin P, Mitchell A, Shmulevich I, Xie L, Caporaso JG, Crandall KA, Simone NL[CRiC], Godoy-Vitorino F, Griffin TJ, Whiteson KL, Gustafson HH, Slade DJ, Schmidt TM, Walther-Antonio MRS, Korem T, Webb-Robertson BM, Styczynski MP, Johnson WE, Jobin C, Ridlon JM, Koh AY, Yu M, Kelly L, Wargo JA. The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View. Trends Cancer[25.5]. 2020 03; 6(3):192-204. PMID: 32101723 PMCID: PMC7098063 PII: S2405-8033(20)30017-0 DOI: 10.1016/j.trecan.2020.01.004 ( Abstract ) iCite Citation Count: 151 iCite RCR: 6.85 (06/02/2025)
|
| ¶ + 40. | Meneveau MO, Petroni GR, Varhegyi NE, Hulse JC, Schroen AT, Brenin DR, Janowski EM, Berger AC, Lazar MA[MORA], Simone NL[CRiC], Showalter TN, Showalter SL. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT. Brachytherapy[3.1]. 2020 Sep - Oct; 19(5):679-684. PMID: 32571746 PMCID: PMC7494626 PII: S1538-4721(20)30088-X DOI: 10.1016/j.brachy.2020.05.002 ( Abstract ) iCite Citation Count: 11 iCite RCR: 0.67 (06/02/2025)
|
| # 41. | Shastri AA, Saleh A, Savage JE, DeAngelis T, Camphausen K, Simone NL[CRiC]. Dietary alterations modulate the microRNA 29/30 and IGF-1/AKT signaling axis in breast Cancer liver metastasis. Nutr Metab (Lond)[7.3]. 2020; 17:23. PMID: 32211051 PMCID: PMC7092508 PII: 437 DOI: 10.1186/s12986-020-00437-z ( Abstract ) iCite Citation Count: 17 iCite RCR: 1.08 (06/02/2025)
|
| + 42. | Song AJ, Manukian G, Taylor AK, Anne PR[MORA], Simone NL[CRiC]. Concerns for Active Breathing Control (ABC) With Breast Cancer in the Era of COVID-19: Maximizing Infection Control While Minimizing Heart Dose. Adv Radiat Oncol[3.8]. 2020 Jul-Aug; 5(4):573-574. PMID: 32292838 PMCID: PMC7118595 PII: S2452-1094(20)30060-9 DOI: 10.1016/j.adro.2020.03.009 ( Abstract ) iCite Citation Count: 7 iCite RCR: 0.47 (06/02/2025)
|
| ¶ † + 43. | Puccetti MV, Adams CM, Dan TD, Palagani A, Simone BA, DeAngelis T, Eischen CM(1)[IRT], Simone NL[CRiC]. MicroRNA-21 is Required for Hematopoietic Cell Viability After Radiation Exposure. Int J Radiat Oncol Biol Phys[10.9]. 2019 08 01; 104(5):1165-1174. PMID: 31039423 PMCID: PMC6986889 PII: S0360-3016(19)30652-2 DOI: 10.1016/j.ijrobp.2019.04.020 ( Abstract ) iCite Citation Count: 7 iCite RCR: 0.32 (06/02/2025)
|
| ¶ 44. | Scott DA, Casadonte R, Cardinali B, Spruill L, Mehta AS, Carli F, Simone N[CRiC], Kriegsmann M, Del Mastro L, Kriegsmann J, Drake RR. Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues. Proteomics Clin Appl[4]. 2019 01; 13(1):e1800014. PMID: 30592377 PMCID: PMC8913074 DOI: 10.1002/prca.201800014 ( Abstract ) iCite Citation Count: 52 iCite RCR: 3.03 (06/02/2025)
|
| # +* 45. | McCall NS, Simone BA, Mehta M, Zhan T, Ko K, Nowak-Choi K, Rese A, Venkataraman C, Andrews DW[IRT], Anne PR[MORA], Dicker AP[CRiC], Shi W[MORA], Simone NL[CRiC]. Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer. Breast Cancer Res Treat[6.1]. 2018 Nov; 172(1):221-230. PMID: 30022328 PMCID: PMC6558990 PII: 10.1007/s10549-018-4880-1 DOI: 10.1007/s10549-018-4880-1 ( Abstract ) iCite Citation Count: 19 iCite RCR: 0.86 (06/02/2025)
|
| # 46. | Simone BA, Ko K, Simone NL[CRiC]. Re: Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases. Breast Cancer Res Treat[6.1]. 2018 11; 172(2):511. PMID: 30259336 PII: 10.1007/s10549-018-4940-6 DOI: 10.1007/s10549-018-4940-6 ( Abstract ) iCite Citation Count: 0 iCite RCR: 0.00 (06/02/2025)
|
| ¶ # * 47. | Simone BA, Palagani A, Strickland K, Ko K, Jin L, Lim MK, Dan TD, Sarich M, Monti DA[CRiC], Cristofanilli M, Simone NL[CRiC]. Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model. Cell Cycle[7.9]. 2018; 17(13):1536-1544. PMID: 29912618 PMCID: PMC6133339 DOI: 10.1080/15384101.2018.1471314 ( Abstract ) iCite Citation Count: 37 iCite RCR: 1.26 (06/02/2025)
|
| ¶ # 48. | Kaidar-Person O, Meattini I, Jain P, Bult P, Simone N[CRiC], Kindts I, Steffens R, Weltens C, Navarria P, Belkacemi Y, Lopez-Guerra J, Livi L, Baumert BG, Vieites B, Limon D, Kurman N, Ko K, Yu JB, Chiang V, Poortmans P, Zagar T. Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study. Breast Cancer Res Treat[6.1]. 2018 01; 167(2):479-483. PMID: 28975433 PII: 10.1007/s10549-017-4526-8 DOI: 10.1007/s10549-017-4526-8 ( Abstract ) iCite Citation Count: 25 iCite RCR: 0.78 (06/02/2025)
|
| ¶ † 49. | Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL[TIPS], Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys[10.9]. 2017 08 01; 98(5):1028-1035. PMID: 28721885 PMCID: PMC5572128 PII: S0360-3016(17)30702-2 DOI: 10.1016/j.ijrobp.2017.03.016 ( Abstract )
|
| ¶ † +* 50. | Toss A, Palazzo J[BC], Berger A[BC], Guiles F, Sendecki JA, Simone N[TIPS], Anne R[BC], Avery T, Jaslow R[BC], Lazar M[BC], Tsangaris T, Cristofanilli M. Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less. Breast[10.4]. 2016 Oct; 29:223-30. PMID: 27506636 PII: S0960-9776(16)30133-3 DOI: 10.1016/j.breast.2016.07.023 ( Abstract )
|
| # 51. | Wright C, Simone NL[TIPS]. Obesity and tumor growth: inflammation, immunity, and the role of a ketogenic diet. Curr Opin Clin Nutr Metab Care[5.9]. 2016 Jul; 19(4):294-9. PMID: 27168354 DOI: 10.1097/MCO.0000000000000286 ( Abstract )
|
| # +* 52. | Shi W, Palmer JD, Werner-Wasik M[CCBS], Andrews DW[CCBS], Evans JJ, Glass J[MBG], Kim L[MBG], Bar-Ad V[CCBS], Judy K, Farrell C, Simone N[TIPS], Liu H, Dicker AP[TIPS], Lawrence YR. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. J Neurooncol[6.1]. 2016 May; 127(3):535-9. PMID: 26821711 PII: 10.1007/s11060-016-2059-3 DOI: 10.1007/s11060-016-2059-3 ( Abstract )
|
| # + 53. | Simone BA, Dan T, Palagani A, Jin L, Han SY, Wright C, Savage JE, Gitman R, Lim MK, Palazzo J[BC], Mehta MP, Simone NL[TIPS]. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer. Cell Cycle[7.9]. 2016 Mar 30:1-10. [Epub ahead of print] PMID: 27027731 PMCID: PMC5004690 DOI: 10.1080/15384101.2016.1160982 ( Abstract )
|
| # * 54. | Kim H, Malatesta TM, Simone NL[TIPS], Den RB[TIPS], McAna J, Dicker AP[TIPS], Bar Ad V. A single activity with a practice quality improvement project for faculty and a quality improvement project for residents. Pract Radiat Oncol[5.4]. 2016 Mar-Apr; 6(2):114-8. PMID: 26723550 PII: S1879-8500(15)00390-2 DOI: 10.1016/j.prro.2015.10.014 ( Abstract )
|
| # +* 55. | Eldredge-Hindy HB, Duffy D, Yamoah K[PC], Simone NL[TIPS], Skowronski J, Dicker AP[TIPS], Anne PR[BC]. Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold. Pract Radiat Oncol[5.4]. 2015 May-Jun; 5(3):162-8. PMID: 25957186 PII: S1879-8500(14)00300-2 DOI: 10.1016/j.prro.2014.10.002 ( Abstract )
|
| # 56. | Dan TD, Simone NL[TIPS]. Not so fast: dietary restriction improves chemotherapy-related toxicity. Cell Cycle[7.9]. 2015; 14(16):2554-5. PMID: 26102577 PMCID: PMC5242323 DOI: 10.1080/15384101.2015.1060777 ( Abstract )
|
| ¶ # + 57. | Eldredge-Hindy H, Lockamy V, Crawford A, Nettleton V, Werner-Wasik M[CCBS], Siglin J, Simone NL[TIPS], Sidhu K, Anne PR[BC]. Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: report of a prospective trial. Pract Radiat Oncol[5.4]. 2015 Jan-Feb; 5(1):4-10. PMID: 25567159 PMCID: PMC4289538 PII: S1879-8500(14)00165-9 DOI: 10.1016/j.prro.2014.06.004 ( Abstract )
|
| # 58. | Dan TD, Wright CM, Simone NL[TIPS]. What benefits could caloric restriction bring to cancer patients? Future Oncol[5.6]. 2014 Dec; 10(16):2543-6. PMID: 25531042 DOI: 10.2217/fon.14.241 ( Abstract )
|
| ¶ † 59. | Palmer JD, Soule BP, Simone BA, Zaorsky NG, Jin L, Simone NL[TIPS]. MicroRNA expression altered by diet: can food be medicinal? Ageing Res Rev[20.6]. 2014 Sep; 17:16-24. PMID: 24833329 PII: S1568-1637(14)00052-X DOI: 10.1016/j.arr.2014.04.005 ( Abstract )
|
| † 60. | Simone BA, Ly D, Savage JE, Hewitt SM, Dan TD, Ylaya K, Shankavaram U, Lim M, Jin L, Camphausen K, Mitchell JB, Simone NL[TIPS]. microRNA alterations driving acute and late stages of radiation-induced fibrosis in a murine skin model. Int J Radiat Oncol Biol Phys[10.9]. 2014 Sep 1; 90(1):44-52. PMID: 24986745 PII: S0360-3016(14)00587-2 DOI: 10.1016/j.ijrobp.2014.05.003 ( Abstract )
|
| # +* 61. | Jin L, Lim M, Zhao S, Sano Y, Simone BA, Savage JE, Wickstrom E[BC], Camphausen K, Pestell RG[BC], Simone NL[TIPS]. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster. Breast Cancer Res Treat[6.1]. 2014 Jul; 146(1):41-50. PMID: 24863696 PMCID: PMC4157915 DOI: 10.1007/s10549-014-2978-7 ( Abstract )
|
| # 62. | Dan T, Hewitt SM, Ohri N, Ly D, Soule BP, Smith SL, Matsuda K, Council C, Shankavaram U, Lippman ME, Mitchell JB, Camphausen K, Simone NL[TIPS]. CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up. Breast Cancer Res Treat[6.1]. 2014 Jan; 143(1):11-8. PMID: 24276281 DOI: 10.1007/s10549-013-2758-9 ( Abstract )
|
| 63. | Eldredge-Hindy HB, Rosenberg AL, Simone NL[TIPS]. Intraoperative radiotherapy for breast cancer: the lasting effects of a fleeting treatment. Int J Breast Cancer[3.7]. 2014; 2014:214325. PMID: 25180098 PMCID: PMC4142745 DOI: 10.1155/2014/214325 ( Abstract )
|
| # * 64. | Wright CM, Dan T, Dicker AP[TIPS], Simone NL[TIPS]. microRNAs: The Short Link between Cancer and RT-Induced DNA Damage Response. Front Oncol[6.9]. 2014; 4:133. PMID: 24926436 PMCID: PMC4044584 DOI: 10.3389/fonc.2014.00133 ( Abstract )
|
| # +* 65. | Simone BA, Champ CE, Rosenberg AL, Berger AC[BC], Monti DA[BC], Dicker AP[TIPS], Simone NL[TIPS]. Selectively starving cancer cells through dietary manipulation: methods and clinical implications. Future Oncol[5.6]. 2013 Jul; 9(7):959-76. PMID: 23837760 DOI: 10.2217/fon.13.31 ( Abstract )
|
| ¶ # +* 66. | Saleh AD, Simone BA, Palazzo J[BC], Savage JE, Sano Y, Dan T, Jin L, Champ CE, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell RG[BC], Mitchell JB, Lisanti MP, Simone NL[TIPS]. Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle[7.9]. 2013 Jun 15; 12(12):1955-63. PMID: 23708519 PMCID: PMC3735710 PII: 25016 DOI: 10.4161/cc.25016 ( Abstract )
|
| ‡ +* 67. | Champ CE, Baserga R, Mishra MV, Jin L, Sotgia F, Lisanti MP, Pestell RG[BC], Dicker AP[TIPS], Simone NL[TIPS]. Nutrient restriction and radiation therapy for cancer treatment: when less is more. Oncologist[9.2]. 2013; 18(1):97-103. PMID: 23299773 PMCID: PMC3556263 PII: theoncologist.2012-0164 DOI: 10.1634/theoncologist.2012-0164 ( Abstract )
|
| ¶ # * 68. | Champ CE, Mishra MV, Showalter TN, Ohri N, Dicker AP[TIPS], Simone NL[TIPS]. Dietary recommendations during and after cancer treatment: consistently inconsistent? Nutr Cancer[6.2]. 2013; 65(3):430-9. PMID: 23530643 DOI: 10.1080/01635581.2013.757629 ( Abstract )
|
| # * 69. | Ørom UA, Lim MK, Savage JE, Jin L, Saleh AD, Lisanti MP[MBG,BBC], Simone NL[BBC]. MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction. Cell Cycle[7.9]. 2012 Apr 1; 11(7):1291-5. PMID: 22421148 PMCID: PMC3350875 PII: 19704 DOI: 10.4161/cc.19704 ( Abstract )
|
| 70. | Champ CE, Volek JS, Siglin J, Jin L, Simone NL[TIPS]. Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? Int J Breast Cancer[3.7]. 2012; 2012:506868. PMID: 23050155 PMCID: PMC3462378 DOI: 10.1155/2012/506868 ( Abstract )
|
| + 71. | Siglin J, Champ CE, Vakhnenko Y, Anne PR[BC], Simone NL[TIPS]. Radiation therapy for locally recurrent breast cancer. Int J Breast Cancer[3.7]. 2012; 2012:571946. PMID: 23091733 PMCID: PMC3471452 DOI: 10.1155/2012/571946 ( Abstract )
|
| # 72. | Simone NL[RRTB], Dan T, Shih J, Smith SL, Sciuto L, Lita E, Lippman ME, Glatstein E, Swain SM, Danforth DN, Camphausen K. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Res Treat[6.1]. 2012 Feb; 132(1):197-203. PMID: 22113254 ( Abstract )
|
| # 73. | Saleh AD, Savage JE, Cao L, Soule BP, Ly D, DeGraff W, Harris CC, Mitchell JB, Simone NL[RRTB]. Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One[5.4]. 2011; 6(10):e24429. PMID: 22022355 PMCID: PMC3191136 ( Abstract )
|
| † 74. | Argiris A, Duffy AG, Kummar S, Simone NL[RRTB], Arai Y, Kim SW, Rudy SF, Kannabiran VR, Yang X, Jang M, Chen Z, Suksta N, Cooley-Zgela T, Ramanand SG, Ahsan A, Nyati MK, Wright JJ, Van Waes C. Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer. Clin Cancer Res[19]. 2011 Sep 1; 17(17):5755-64. PMID: 21750205 PMCID: PMC3368806 ( Abstract )
|
| † 75. | Simone CB, Lonser RR, Ondos J, Oldfield EH, Camphausen K, Simone NL[RRTB]. Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas. Neuro Oncol[30.2]. 2011 Sep; 13(9):1030-6. PMID: 21798886 PMCID: PMC3158017 ( Abstract )
|
| ‡ 76. | Simone CB, Ly D, Dan TD, Ondos J, Ning H, Belard A, O'Connell J, Miller RW, Simone NL[RRTB]. Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol[9.1]. 2011 Dec; 101(3):376-82. PMID: 21663988 PMCID: PMC3174314 ( Abstract )
|
Same as historical except includes Associate members (and their publications) after 2017.
There were 76 publications authored by SIMONE N as a SKCCC Member from 01/01/2000 to Present.
25 publications(32.89%) were inter-programmatic(+ or +*).
34 publications(44.74%) were intra-programmatic(* or +*).
Omitting Journals with an undefined CiteScore
15 publications(20.27%) had an CiteScore ≥ 10 (†).
24 publications(32.43%) had an CiteScore ≥ 9 († or ‡).
53 publications(71.62%) had an CiteScore ≥ 5 († or ‡ or #).
Average CiteScore [666.8/74]: 9.01.
There were 4 inter-institutional publications(§).
Collaborative Publications With Other NCI Designated Cancer Centers
There were 31 publications with other Cancer Centers (¶) (31/71) or 43.66% of the publications that were reviewed for collaboration by SKCCC Authors or Administration. This has only been tracked since 2012.
Average iCite Citation Count (only tracking for post 2018 publications) (774/48): 16.13
iCite h-index (based on documents listed): 14
Average iCite Relative Citation Rate (62.57/42): 1.49
The selected author's name appears in bold with program at the time of publication. Other SKCCC members and their programs are italicized.
Current Codes/Programs
CRiC: Cancer Risk and Control
IRT: Immune Cell Regulation and Targeting
MORA: Molecular Oncology Regulation and Approaches
TaCO: Translational and Cellular Oncology
ZY: Non-Programmatically Aligned
(1) - Author was Co-Corresponding/Senior Author
The SKCCC Publication database is usually updated weekly or bi-weekly, the last update was completed on 12/19/2025.
Currently using 2024/25 Scopus CiteScores from scopus.com
iCite Citation Data (Count and Relative Citation Rate) loaded automatically (monthly) from https://icite.od.nih.gov/
Citation Counts Are Only Being Loaded/Updated For Publications Published After 1/1/2018
|
